Form D · Other Health Care
O'Ryan Therapeutics, Inc.
Wellesley, MA · CIK 0001992190
Offering snapshot reported Sep 8, 2023 · SEC filing
- Reported sold
- $40K Offering amount: $600K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 29, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 8, 2023 | Initial | $40,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-491695
Source: Form D, filed Sep 8, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tim Coleman | Director, Executive |
| Michael Parnell | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
33 Kirkland Circle
Wellesley, MA, 02481
Wellesley, MA, 02481